Literature DB >> 1353987

Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.

K Lorré1, L Fransen, J L Ceuppens.   

Abstract

We examined requirements for TNF-alpha production by purified human blood T cells, completely depleted of monocyte-accessory cells, under different conditions of stimulation. Activation of T cells with immobilized anti-CD3 induced the appearance of mRNA for TNF-alpha and of functionally active TNF-alpha in the culture supernatant. Anti-CD3-induced TNF-alpha production could be inhibited by blocking the IL-2R with a combination of anti-Tac and Mik beta 1 (mAbs against the p55 and p75 chain of the IL-2R respectively) thus indicating an essential role of IL-2 in TNF-alpha induction. When purified T cells were activated with a combination of two anti-CD2 mAbs (9-1 and 9.6), additional signals (rIL-2 or rIL-1 beta or anti-CD28) were required for TNF-alpha mRNA production and protein secretion. rIL-1 beta supported anti-CD2-induced TNF-alpha production indirectly through an IL-2-dependent pathway. These same helper signals also enhanced TNF-alpha production by anti-CD3-stimulated T cells. IL-4, IL-6, GM-CSF and IFN-gamma had no effect on TNF-alpha production by T cells activated via either pathway. Addition of rIL-1 beta alone, rIL-2 alone or endotoxins to resting human T cells did not induce detectable amounts of TNF-alpha. Both helper/inducer CD4(+) and suppressor/cytotoxic CD8(+) subsets of T cells were shown to produce TNF-alpha upon stimulation. We conclude that CD3 or CD2 triggering are not sufficient for TNF-alpha production by T cells, but that the latter is dependent (apparently at the transcriptional level) on the interaction of IL-2 with its functionally active cell surface receptors. We could further demonstrate that TNF-alpha production was completely blocked by cyclosporin A. The inhibitory effect of this agent on TNF-alpha production was also observed in the presence of rIL-2, thus excluding an indirect effect through inhibition of IL-2 production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1353987

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  6 in total

1.  A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia.

Authors:  Qian Zhang; Morgan E Hresko; Lora K Picton; Leon Su; Michael J Hollander; Selene Nunez-Cruz; Zheng Zhang; Charles-Antoine Assenmacher; Jonathan T Sockolosky; K Christopher Garcia; Michael C Milone
Journal:  Sci Transl Med       Date:  2021-12-22       Impact factor: 19.319

2.  The effects of monocytes on the transendothelial migration of T lymphocytes.

Authors:  E A Lidington; A M McCormack; M H Yacoub; M L Rose
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

3.  Dual Infection with Dengue Virus Serotype 1 and 2 in a Patient in Western Mexico.

Authors:  Francisco Espinoza-Gómez; Iván Delgado-Enciso; Salvador Valle-Reyes; Clemente Vásquez; Uriel A López-Lemus
Journal:  J Glob Infect Dis       Date:  2017 Oct-Dec

4.  Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study.

Authors:  Suresh Pallikkuth; Lesley R de Armas; Stefano Rinaldi; Varghese K George; Li Pan; Kristopher L Arheart; Rajendra Pahwa; Savita Pahwa
Journal:  PLoS Biol       Date:  2019-05-17       Impact factor: 8.029

5.  An Immunosuppressive Effect of Melanoma-derived Exosomes on NY-ESO-1 Antigen-specific Human CD8+ T Cells is Dependent on IL-10 and Independent of BRAFV600E Mutation in Melanoma Cell Lines.

Authors:  ShinLa Shu; Junko Matsuzaki; Muzamil Y Want; Alexis Conway; Shawna Benjamin-Davalos; Cheryl L Allen; Marina Koroleva; Sebastiano Battaglia; Adekunle Odunsi; Hans Minderman; Marc S Ernstoff
Journal:  Immunol Invest       Date:  2020-08-17       Impact factor: 3.044

6.  An Emerging Syndemic of Smoking and Cardiopulmonary Diseases in People Living with HIV in Africa.

Authors:  Emmanuel Peprah; Mari Armstrong-Hough; Stephanie H Cook; Barbara Mukasa; Jacquelyn Y Taylor; Huichun Xu; Linda Chang; Joyce Gyamfi; Nessa Ryan; Temitope Ojo; Anya Snyder; Juliet Iwelunmor; Oliver Ezechi; Conrad Iyegbe; Paul O'Reilly; Andre Pascal Kengne
Journal:  Int J Environ Res Public Health       Date:  2021-03-18       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.